Our Goals

  1. Distribute of up-to-date medical information on lung cancer
  2. Provide mental support and guidance for patients and families coping with lung cancer
  3. Make personalized medicine accessible to patients
  4. Help to exercise social rights
  5. Support funding and promotion of lung cancer research
  6. Encourage programs for early diagnosis of lung cancer
  7. Activities to expand the Israeli medicine basket for patients at risk and those suffering or recovering from lung cancer
  8. Promote public activity against the tobacco concern to limit smoking and to reduce the number of smokers in Israel

About ILCF

The Israeli Lung Cancer Foundation was established in April 2014.
It is an apolitical organization that deals with issues related to patients at risk or who have suffered or suffering from lung cancer and their families. The Israeli Lung Cancer Foundation supports the oncology patient and his caregivers, including assistance in medical information, making inquiries about advanced treatments, prevention, early detection, and more. We are the voice and face of lung cancer patients, esteblished a sharing community and represent this comunity to stakeholders. The organization promotes the incorporation of lung cancer screening in the Israeli health system.
It is a non-profit organization, committed to the code of ethics.

Our Vision

Our Vision

A world in which lung cancer is a preventable, treatable, and curable disease. A world in which lung cancer patients and their families enjoy optimal quality of life.

The Founders

Prof. Nir Peled

Prof. Peled is an expert in internal medicine, lung and oncology, Head of Helmsely Cancer Center Shaare Zedek Medical Center.

Prof. Peled is Chairman of the Lung Cancer Department of the European Lung Association and Chairman of the International Committee for the Prevention and Early Diagnosis of Lung Cancer.
Prof. Peled is a pioneer in early diagnosis of lung cancer and the implementation of personalized medicine using biological treatments.

Dr. Shani Shilo

Dr. Shilo, a dentist and PhD holder in biochemistry from the Hebrew University of Jerusalem, a postdoctoral fellow at the Ohio State University in the field of wound healing, is engaged in biotech research and development. Her husband was diagnosed in July 2011 with stage IV lung cancer, at the age of 43, a never smoker.
During this journey and coping with her husbands disease, the experience that was acquired, the understanding of the unmet needs for the patient and the caregiver, Dr. Shilo decided to establish the first patient organization in the field of lung cancer in Israel. Shani and her husband have two children who were 9 and 6 years old at the time of diagnosis
Elad passed away in August 2022.

Board Members

LIAN IPALE-ZVI

Lian's daughter was diagnosed with stage 4 lung cancer at the age of 19, while still serving in the IDF. Since then, the girl has been doing well and is being treated thanks to new developments in the field of lung cancer. Lian has another daughter, and she works as a manager in the field of foreign workers in the agricultural sector, holds a mediator certificate from Bar Ilan University and has a law degree.

DR. ABED AGBARIA

Dr. Abed Agbaria, an oncologist, Director of the Oncology Institute at Bnei Zion Hospital, Director of the Community Oncology Unit of Clalit Health Services in Nazareth, and Lecturer at the Faculty of Medicine at the Technion. Dr. Agbaria treats thoracic tumors and is considered one of the leading experts in the field of lung cancer treatment. In addition, Dr. Agbaria is an active member of the Pulmonary Section of the Israeli Society for Clinical Oncology and Radiotherapy and is responsible for the Northern Lung Forum, which consists of a variety of medical professionals.

Accountant Tamir Abudi

Has financial expertise and extensive managerial and business experience in the energy market, served for several years in the US as president of an oil and gas company. Manages and assists with projects, acquisitions and mergers, capital raisings and financing in the hundreds of millions of dollars in the oil and gas market in Israel and abroad.
Serves as a member of the board of directors of the Tamar Petroleum Natural Gas Corporation and served as the company's interim CEO in the first half of 2022. Previously served as CEO and Chief Financial Officer of a group of international companies in the field of medical equipment and supplies marketing and as a partner in a large accounting firm. Tamir is an accountant by training and holds a degree in accounting and economics from Tel Aviv University.

DR. SHANI ATIA KONYO

Dr. Konyo was a third-year medical student at Tel Aviv University when her mother Paula was diagnosed with stage 4 lung cancer at the age of 48. Pola passed away a year later. Shani is currently married and the mother of 3 daughters, and is an internal medicine specialist at Tel Hashomer Medical Center.

Yehudit leffler lerer

EMBA graduate, VP of Marketing, Segal Group

Our Sponsors

astrazeneca-large
boehringer-ingelheim-logo
bristol-myers
logMSD
Novartis-Oncology
pfizer
Roche_small
takeda-logo
RH_ONCOTEST_LOGO

Contact Us

Follow Us